Mylan Pharmaceuticals has come under intense fire for massive price hikes of EpiPens over the last week, facing scrutiny from lawmakers and industry groups. It is less well known, however, that while Mylan markets and prices the drug, Pfizer Inc. actually manufactures the drug and has seen increased revenues from EpiPens over the last few years.
Republicans and Democrats alike have both demanded information from Mylan about how it sets EpiPen prices, and Hillary Clinton on Wednesday called the price increases “outrageous.” However, little to no attention has been given to Pfizer.
Read Full Article »